Biophore Pharma Inc

General

Total Cases6
Active Cases--
Patents--
TypeOperating Company
Elite Ratings
--
--
--
--

Ratings

Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered
Case
Description
11/05/24
***Civil Case Administratively Terminated. (jd, ) (Entered: 11/05/2024)
11/05/24
***Civil Case Administratively Terminated. (jd, ) (Entered: 11/05/2024)
11/05/24
ORDER CONSOLIDATING Cases for all purposes, including discovery, case management, and trial, subject to further Order of the Court. All filings going forward shall be filed in Civil Action No. 23-3914, and that Civil Action Nos. 23-23141, and 24-7550 shall be administratively terminated by the Clerk's Office. Signed by Magistrate Judge Andre M. Espinosa on 11/4/2024. (jd, ) (Entered: 11/05/2024)
11/05/24
ORDER CONSOLIDATING Cases for all purposes, including discovery, case management, and trial, subject to further Order of the Court. All filings going forward shall be filed in Civil Action No. 23-3914, and that Civil Action Nos. 23-23141, and 24-7550 shall be administratively terminated by the Clerk's Office. Signed by Magistrate Judge Andre M. Espinosa on 11/4/2024. (jd, ) (Entered: 11/05/2024)
11/04/24
Letter from Plaintiff to the Hon. Andre M. Espinosa, U.S.M.J.. (SULLIVAN, SARAH) (Entered: 11/04/2024)
11/04/24
Letter from Plaintiff to the Hon. Andre M. Espinosa, U.S.M.J.. (SULLIVAN, SARAH) (Entered: 11/04/2024)
11/01/24
Letter from Plaintiff to the Hon. Michael E. Farbiarz, U.S.D.J.. (LIZZA, CHARLES) (Entered: 11/01/2024)
11/01/24
Letter from Plaintiff to the Hon. Michael E. Farbiarz, U.S.D.J.. (LIZZA, CHARLES) (Entered: 11/01/2024)
10/29/24
ANSWER to Counterclaim Jazz Pharmaceuticals Research UK Limited's Answer to the InvaGen Defendants' Counterclaims by JAZZ PHARMACEUTICALS RESEARCH UK LIMITED. (Attachments: # [1] Certificate of Service)(LIZZA, CHARLES) (Entered: 10/29/2024)
10/29/24
PRETRIAL SCHEDULING ORDER. Signed by Magistrate Judge Andre M. Espinosa on 10/28/2024. (jd, ) (Entered: 10/29/2024)